Structures published

Total: 25

4-(4-Chlorophenyl)-1,2,3-selenadiazole

C₈H₅ClN₂Se

Ravichandran, K.Ranjith, S.Sankari, S.Beemarao, M.Ponnuswamy, M. N.

IUCrData (2018) 3, 3 x180462

a=10.3353(9)Å b=14.0058(12)Å c=5.9540(4)Å

α=90° β=97.320(3)° γ=90°

N-acetyl-3-isopropyl-2,6-diphenylpiperidine

C₂₂H₂₇NO

Periyannan, P.Beemarao, M.Karthik, K.Ponnuswamy, S.Ravichandran, K.

Acta Crystallographica Section E (2020) 76, 3 377-381

a=13.3077(5)Å b=10.3009(4)Å c=13.9338(5)Å

α=90° β=104.6570(10)° γ=90°

2-Amino-4-(2-chlorophenyl)-7-hydroxy-4H-benzo[1,2-b]pyran-3-carbonitrile

C₁₆H₁₁ClN₂O₂

Beemarao, M.Silambarasan, S.Nasser, A. Jamal Abdul Purushothaman, M.Ravichandran, K.

Acta Crystallographica Section E (2019) 75, 11 1638-1642

a=6.6658(3)Å b=30.1600(16)Å c=7.2193(4)Å

α=90° β=106.088(2)° γ=90°

C₂₆H₂₂N₂O₆S₂

Subramanian, E.Govindasamy, L.Ravichandran, K.

Acta Crystallographica Section C (1997) 53, 7 925-927

a=10.9560(10)Å b=14.6260(10)Å c=7.6060(10)Å

α=93.660(10)° β=92.060(10)° γ=92.590(10)°

5-Chloroacetyl-4-methyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one

C₁₂H₁₃ClN₂O₂

Ravichandran, K.Sakthivel, P.Ponnuswamy, S.Ramesh, P.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 10 o2361

a=16.7656(4)Å b=8.8171(2)Å c=17.0125(4)Å

α=90.00° β=105.8030(10)° γ=90.00°

4-Methyl-2-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-5-carbaldehyde

C₁₁H₁₂N₂O₂

Ravichandran, K.Sakthivel, P.Ponnuswamy, S.Ramesh, P.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 10 o2362

a=5.32840(10)Å b=12.9387(4)Å c=14.6227(5)Å

α=90.00° β=97.968(2)° γ=90.00°

N~5~-Dichloroacetyltetrahydro-4-methyl-1,5-benzodiazepin-2-one hemihydrate

2(C₁₂H₁₂Cl₂N₂O₂)_,H₂O

Ravichandran, K.Sakthivel, P.Ponnuswamy, S.Shalini, M.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 10 o2551-o2552

a=8.5470(3)Å b=18.0837(6)Å c=8.8697(3)Å

α=90.00° β=95.405(2)° γ=90.00°

2,2,4-Trimethyl-5-(4-tolylsulfonyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine

C₁₉H₂₄N₂O₂S

Ravichandran, K.Sathiyaraj, K.Ilango, S. S.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 10 o2363-o2364

a=7.3658(3)Å b=14.8013(8)Å c=17.4556(10)Å

α=90.00° β=90.00° γ=90.00°

(Benzylamine)chloridobis(ethane-1,2-diamine)cobalt(III) dichloride hemihydrate

C₁₁H₂₅ClCoN_52,2(Cl)_,0.5(H₂O)

Ravichandran, K.Ramesh, P.Tamilselvan, M.Anbalagan, K.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 10 m1174-m1175

a=20.9361(9)Å b=7.2447(3)Å c=24.4340(9)Å

α=90.00° β=106.440(2)° γ=90.00°

1-chloroacetyl-2,6-bis(2-chlorophenyl)-3,5-dimethyl-piperidin-4-one oxime

C₂₁H₂₁Cl₃N₂O₂

Ravichandran, K.Ramesh, P.Rani, M.Kabilan, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2010) 66, 6 o1506

a=9.8147(6)Å b=15.5929(11)Å c=13.9498(9)Å

α=90.00° β=93.529(4)° γ=90.00°

1-Formyl-t-3,t-5-dimethyl-r-2,c-6-diphenylpiperidin-4-one

C₂₀H₂₁NO₂

Ravichandran, K.Ramesh, P.Sakthivel, P.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2010) 66, 6 o1505

a=7.4303(4)Å b=15.3567(6)Å c=29.6732(13)Å

α=90.00° β=90.00° γ=90.00°

2-Methoxyquinoline-3-carbaldehyde

C₁₁H₉NO₂

Chandraprakash, K.Ramesh, P.Ravichandran, K.Mohan, P. S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2010) 66, 10 o2510

a=8.8206(6)Å b=4.8446(3)Å c=21.6828(14)Å

α=90.00° β=90.612(4)° γ=90.00°

Chloridobis(ethane-1,2-diamine)(4-methylaniline)cobalt(III) dichloride monohydrate

C₁₁H₂₅ClCoN_52,2(Cl)_,H₂O

Ravichandran, K.Ramesh, P.Mahalakshmi, C. Maharaja Anbalagan, K.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 11 m1458-m1459

a=7.3796(2)Å b=10.8367(3)Å c=12.1789(3)Å

α=75.2010(10)° β=74.671(2)° γ=78.8620(10)°

1-Chloroacetyl-r-2,c-6-bis(4-methoxyphenyl)-t-3-methylpiperidin-4-one

C₂₂H₂₄ClNO₄

Ravichandran, K.Ramesh, P.Sakthivel, P.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 11 o2883

a=8.9147(8)Å b=11.9648(10)Å c=19.1365(16)Å

α=99.729(5)° β=93.665(5)° γ=90.112(6)°

c-3,t-3-Dimethyl-r-2,c-7-diphenyl-1,4-diazepan-5-one

C₁₉H₂₂N₂O

Ravichandran, K.Ramesh, P.Sethuvasan, S.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 11 o2884

a=6.7354(4)Å b=10.6867(6)Å c=11.4186(7)Å

α=82.191(3)° β=88.218(4)° γ=80.317(3)°

t-3-Ethyl-r-2,c-7-bis(4-methoxyphenyl)-1,4-diazepan-5-one

C₂₁H₂₆N₂O₃

Ravichandran, K.Ramesh, P.Sethuvasan, S.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 11 o2885-o2886

a=10.5190(3)Å b=13.3480(4)Å c=15.0472(4)Å

α=102.118(2)° β=93.662(2)° γ=110.287(2)°

(E)-3-(4-bromophenyl)-3-[3-(4-bromophenyl)-1H-pyrazol-1-yl]-2-propenal

C₁₈H₁₂Br₂N₂O

Ramesh, P.Manikannan, Ramaiyan Muthusubramanian, S.Ravichandran, K.Ponnuswamy, M. N.

Acta Crystallographica Section E (2010) 66, 2 o279

a=9.2600(3)Å b=9.3782(3)Å c=37.9965(4)Å

α=90.00° β=90.00° γ=90.00°

1-Dichloroacetyl-r-2,c-6-bis(4-methoxyphenyl)-t-3,t-5-dimethylpiperidin-4-one

C₂₃H₂₅Cl₂NO₄

Ravichandran, K.Ramesh, P.Neeladevi, C.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2010) 66, 2 o263

a=8.1251(7)Å b=9.9702(9)Å c=27.649(2)Å

α=90.00° β=92.265(5)° γ=90.00°

1-Chloroacetyl-3-isopropyl-r-2,c-6-diphenylpiperidin-4-one

C₂₂H₂₄ClNO₂

Ravichandran, K.Ramesh, P.Jeganathan, P.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2010) 66, 2 o276-o277

a=10.3415(12)Å b=9.0243(9)Å c=21.438(2)Å

α=90.00° β=90.894(3)° γ=90.00°

1-Acetyl-t-3-ethyl-r-2,c-6-bis(4-methoxyphenyl)piperidin-4-one

C₂₃H₂₇NO₄

Ravichandran, K.Ponnuswamy, S.Rajesh, R.Mohanraj, V.Ponnuswamy, M. N.

Acta Crystallographica Section E (2010) 66, 2 o275

a=8.6736(11)Å b=13.4578(16)Å c=17.547(2)Å

α=90.00° β=90.00° γ=90.00°

1-Dichloroacetyl-r-2,c-6-bis(4-methoxyphenyl)-t-3-methylpiperidin-4-one

C₂₂H₂₃Cl₂NO₄

Ravichandran, K.Ramesh, P.Sakthivel, P.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2010) 66, 2 o262

a=19.3021(16)Å b=10.5886(9)Å c=10.3241(10)Å

α=90.00° β=91.445(5)° γ=90.00°

8-Methoxy-3,3,5-trimethyl-3,11-dihydropyrano[3,2-a]carbazole

C₁₉H₁₉NO₂

Uvarani, C.Ramesh, P.Ravichandran, K.Mohan, P. S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2010) 66, 7 o1581

a=8.290(5)Å b=8.693(5)Å c=21.326(5)Å

α=90.000(5)° β=90.742(5)° γ=90.000(5)°

({[(Carboxymethyl)sulfanyl](2-hydroxyphenyl)methyl}sulfanyl)acetic acid

C₁₁H₁₂O₅S₂

Ravichandran, K.Manikannan, R.Muthusubramanian, S.Ramesh, P.Ponnuswamy, M. N.

Acta Crystallographica Section E (2013) 69, 6 o893

a=7.24650(10)Å b=7.65330(10)Å c=12.0141(2)Å

α=101.094(2)° β=99.1290(10)° γ=102.390(2)°

1-Formyl-c-3,t-3-dimethyl-r-2,c-6-diphenylpiperidin-4-one

C₂₀H₂₁NO₂

Ravichandran, K.Sakthivel, P.Ramesh, P.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2012) 68, 3 o870

a=10.6604(6)Å b=15.7278(7)Å c=10.8066(5)Å

α=90.00° β=110.120(2)° γ=90.00°

3-Isopropyl-2,6-bis(4-methoxyphenyl)piperidin-4-one

C₂₂H₂₇NO₃

Ravichandran, K.Sethuvasan, S.Thirunavukarasu, K.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2012) 68, 8 o2453

a=7.5547(3)Å b=11.8792(6)Å c=22.1103(10)Å

α=90.00° β=90.00° γ=90.00°

Structures by: Ravichandran K.

Total: 25

4-(4-Chlorophenyl)-1,2,3-selenadiazole

<i>N</i>-acetyl-3-isopropyl-2,6-diphenylpiperidine

2-Amino-4-(2-chlorophenyl)-7-hydroxy-4<i>H</i>-benzo[1,2-<i>b</i>]pyran-3-carbonitrile

C₂₆H₂₂N₂O₆S₂

5-Chloroacetyl-4-methyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one

4-Methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepine-5-carbaldehyde

N~5~-Dichloroacetyltetrahydro-4-methyl-1,5-benzodiazepin-2-one hemihydrate

2,2,4-Trimethyl-5-(4-tolylsulfonyl)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepine

(Benzylamine)chloridobis(ethane-1,2-diamine)cobalt(III) dichloride hemihydrate

1-chloroacetyl-2,6-bis(2-chlorophenyl)-3,5-dimethyl-piperidin-4-one oxime

1-Formyl-<i>t</i>-3,<i>t</i>-5-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one

2-Methoxyquinoline-3-carbaldehyde

Chloridobis(ethane-1,2-diamine)(4-methylaniline)cobalt(III) dichloride monohydrate

1-Chloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3-methylpiperidin-4-one

<i>c</i>-3,<i>t</i>-3-Dimethyl-<i>r</i>-2,<i>c</i>-7-diphenyl-1,4-diazepan-5-one

<i>t</i>-3-Ethyl-<i>r</i>-2,<i>c</i>-7-bis(4-methoxyphenyl)-1,4-diazepan-5-one

(E)-3-(4-bromophenyl)-3-[3-(4-bromophenyl)-1H-pyrazol-1-yl]-2-propenal

1-Dichloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3,<i>t</i>-5-dimethylpiperidin-4-one

1-Chloroacetyl-3-isopropyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one

1-Acetyl-<i>t</i>-3-ethyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)piperidin-4-one

1-Dichloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3-methylpiperidin-4-one

8-Methoxy-3,3,5-trimethyl-3,11-dihydropyrano[3,2-<i>a</i>]carbazole

({[(Carboxymethyl)sulfanyl](2-hydroxyphenyl)methyl}sulfanyl)acetic acid

1-Formyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one

3-Isopropyl-2,6-bis(4-methoxyphenyl)piperidin-4-one